Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima P Porten

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Urology|December 19, 2009
Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasisBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
BMC Urology|April 19, 2020
A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer DatabaseKyle B Zuniga, Samuel L Washington, Sima P Porten, et al.
Urology Practice|August 18, 2023
The Efficient and Effective Use of Exfoliative Urinary MarkersJared M Whitson, Sima P Porten, Ahmed A Hussein, et al.
Clinical Epigenetics|February 20, 2018
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinomaThomas Sanford, Maxwell V Meng, Reema Railkar, et al.
Urology|June 12, 2021
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer CohortMeera R Chappidi, Christopher Welty, Woonyoung Choi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
The role of active surveillance in the management of prostate cancerSimon D Fung-Kee-Fung, Sima P Porten, Maxwell V Meng, et al.
Plos One|November 16, 2017
Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumorsKarla J Lindquist, Thomas Sanford, Terence W Friedlander, et al.
Urologic Oncology|May 31, 2023
Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocolsMeera R Chappidi, Domenique Escobar, Maxwell V Meng, et al.
Cancer Medicine|March 30, 2024
Association of household net worth with healthcare costs after radical cystectomy using real-world dataSamuel L Washington, Peter E Lonergan, Anobel Y Odisho, et al.
Cancer Medicine|September 2, 2020
Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancerSamuel L Washington, Steven E Gregorich, Maxwell V Meng, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Urology|December 19, 2009
Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasisBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
BMC Urology|April 19, 2020
A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer DatabaseKyle B Zuniga, Samuel L Washington, Sima P Porten, et al.
Urology Practice|August 18, 2023
The Efficient and Effective Use of Exfoliative Urinary MarkersJared M Whitson, Sima P Porten, Ahmed A Hussein, et al.
Clinical Epigenetics|February 20, 2018
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinomaThomas Sanford, Maxwell V Meng, Reema Railkar, et al.
Urology|June 12, 2021
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer CohortMeera R Chappidi, Christopher Welty, Woonyoung Choi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
The role of active surveillance in the management of prostate cancerSimon D Fung-Kee-Fung, Sima P Porten, Maxwell V Meng, et al.
Plos One|November 16, 2017
Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumorsKarla J Lindquist, Thomas Sanford, Terence W Friedlander, et al.
Urologic Oncology|May 31, 2023
Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocolsMeera R Chappidi, Domenique Escobar, Maxwell V Meng, et al.
Cancer Medicine|March 30, 2024
Association of household net worth with healthcare costs after radical cystectomy using real-world dataSamuel L Washington, Peter E Lonergan, Anobel Y Odisho, et al.
Cancer Medicine|September 2, 2020
Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancerSamuel L Washington, Steven E Gregorich, Maxwell V Meng, et al.
Pageof 9